Earum Pharmaceuticals Ltd - 542724 - Outcome Of Board Meeting Held On 21.07.2021
Outcome of Board Meeting held on 21.07.202121-07-2021
21-07-2021
Earum Pharmaceuticals Ltd - 542724 - Submission Of Voting Results And Scrutinizers Report Of Postal Ballot- Signed
Dear Sir/Madam, Pursuant to Regulation 44(3) of the SEBI (LODR), Regulations, 2015, we hereby submit the Scrutinizer''''s Report and details regarding voting for the resolutions as embodied in the Postal Ballot Notice dated June 10, 2021. Kindly take the above information on your record. Thanking You. Yours Faithfully,20-07-2021
Earum Pharmaceuticals Ltd - 542724 - Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Earum Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here19-07-2021
Earum Pharmaceuticals Ltd - 542724 - Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Earum Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here19-07-2021
Earum Pharmaceuticals Ltd - 542724 - Submission Of Voting Results And Scrutinizers Report Of Postal Ballot
Dear Sir/Madam, Pursuant to Regulation 44(3) of the SEBI (LODR), Regulations, 2015, we hereby submit the Scrutinizer''s Report and details regarding voting for the resolutions as embodied in the Postal Ballot Notice dated June 10, 2021. Kindly take the above information on your record. Thanking You. Yours Faithfully,19-07-2021
Earum Pharmaceuticals Ltd - 542724 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
CERTIFICATE UNDER REGULATION 74(5) OF SEBI (DEPOSITORIES AND PARTICIPANTS) REGULATIONS, 2018 FOR QUARTER ENDED ON JUNE 30, 202114-07-2021
Earum Pharmaceuticals Ltd - 542724 - Board Meeting Intimation for Board Meeting Intimation To Consider Migration From SME Platform Of BSE To The Main Board Of NSE
Earum Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/07/2021 ,inter alia, to consider and approve Dear Sir/Madam, We hereby inform you that, pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015, a meeting of the Board of Directors of the Company will be held on Wednesday, 21st July, 2021 at the Corporate Office of the Company Situated At A-1106, Empire Business Hub, Near Auda Water Tank, Science City Road, Sola, Ahmedabad, Gujarat - 380060, inter alia to transact the following business: 1. To Consider Migration from SME Platform of BSE to the Main Board of NSE 2. Any other business with the permission of the Chair This is for your information and record. Thank you.13-07-2021
Earum Pharmaceuticals Ltd - 542724 - Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Priya RavalDesignation :- Company Secretary and Compliance Officer02-07-2021
Earum Pharmaceuticals Ltd - 542724 - Appointment of Company Secretary and Compliance Officer
Appointment of Ms. Priya Alpesh Raval as Company Secretary and Compliance Officer of the Company01-07-2021
Earum Pharmaceuticals Ltd - 542724 - Appointment Of Ms. Priya Alpesh Raval As Company Secretary And Compliance Officer Of The Company
Intimation of Appointment of Ms. Priya Alpesh Raval as Company Secretary and Compliance Officer of the Company under Regulation 30 of SEBI (Listing obligation and Disclosure Requirements) Regulations, 201501-07-2021